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Abstract The effect of cupric ion- or endothelial cell-oxidized 
low-density lipoproteins (LDL) on transcription factor API 
activation was investigated by electrophoretic mobility shift 
assay. Both oxidized LDL induced API activation in fibroblasts, 
endothelial and smooth muscle cells. This phenomenon was also 
observed in the presence of cycloheximide. a-Tocopherol, a 
lipophilic free radical scavenger, and TV-acetylcysteine, an 
hydrophilic antioxidant, partially inhibited the stimulatory effect 
of Cu2+-oxidized LDL. LDL modified by the mixture of the 
oxygen radicals OH- and 0 2 - , which generated lipid peroxida-
tion products, also initiated API activation, whereas LDL 
modified by OH- alone, which did not lead to marked LDL lipid 
peroxidation, was ineffective. Thus, lipid peroxidation products 
seem at least partially involved in the activation mechanism. 
Since API activity is essential for the regulation of genes 
involved in cell growth and differentiation, our study suggests 
that the oxidative stress induced by oxidized LDL might be 
related to the fibroproliferative response observed in the 
atherosclerotic plaque. 
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1. Introduction 
It is currently believed that oxidized low-density lipopro-
teins (LDL) play an important role in the generation and 
progression of the atherosclerotic plaque (review in [1]). Oxi-
dative modification of L D L can be achieved by incubation 
with cultured cells such as monocytes [2], endothelial [3] or 
smooth muscle cells [4]. In vitro, transition metals such as 
copper can also initiate L D L oxidation [5], leading to a cyto-
toxic form of the particle. The oxidative modification of L D L 
is accompanied by the appearance of conjugated dienes and 
lipid peroxidation end-products [6]. A modification of the 
electrophoretic mobility of the particle was also observed [7]. 
API (activator protein 1) is a transcriptional activator com-
posed of members of the Jun and Fos families (review in [8]) 
that mediates the effect of the phorbol ester tumor promoter 
*Corresponding author. Fax: +33 (1) 2266 8593. 
Abbreviations: c-LDL, control low-density lipoprotein; Cu-LDL, 
Cu2+-oxidized LDL; E-LDL, endothelial cell-oxidized LDL; TBARS, 
thiobarbituric-acid-reactive substances (lipid peroxidation end-
products) 
12-O-tetradecanoyl phorbol- 13-acetate [9]. API activation can 
be induced by growth factors, cytokines and neurotransmit-
ters [8]. Furthermore, A P I binding activity is controlled by 
the redox state of the cell in that a decrease of the intracellular 
glutathione level stimulates API activity [10]. It has been also 
shown that the oxidative stress induced by ultraviolet radia-
tion activates API [11,12]. More recently, Pinkus et al. [13] 
reported stimulation of API activity by oxygen radicals. 
This study was undertaken to investigate whether the oxi-
dative stress induced by copper- or cell-oxidized L D L can 
activate the transcription factor A P I . It was found that 
both oxidized L D L stimulated API binding activity in fibro-
blasts, smooth muscle and endothelial cells. In addition, oc-
tocopherol significantly reduces the oxidized LDL-induced ac-
tivation of A P I . 
2. Materials and methods 
2.1. Materials 
Culture medium and foetal calf serum were from Gibco (Grand 
Island, NY, USA). The double-stranded oligonucleotide containing 
the API consensus sequence (5'-AGC-TAG-GTG-ACT-CAC-
CAA-GCT-TCG-A-3') was synthesized by Eurogentec (Belgium). 
[y-32P]ATP 3000 Ci/mmol was purchased from Amersham. T4 poly-
nucleotide kinase was obtained from Boehringer Mannheim (Meylan, 
France). rf/-cc-Tocopherol and all other chemicals were from Sigma 
(St. Louis, MO, USA). 
2.2. Cell culture 
A7r5 rat smooth muscle cells from The American Type Culture 
Collection, and MRC5 human fibroblasts from BioMérieux (France) 
were maintained in Dulbecco's MEM supplemented with 10% foetal 
calf serum. The murine endothelial cell line UNA was a gift from Pr. 
J.D. Chapman (The Fox Chase Cancer Center, Philadelphia, PA, 
USA). This cell line was characterized by the presence of von Wille-
brand's factor and was maintained in Ham's F10 medium supple-
mented with 10% foetal calf serum. 
2.3. LDL preparation and oxidation 
LDL (d 1.024-1.050) was prepared from normal human serum by 
sequential ultracentrifugation according to Havel et al. [14], and dia-
lysed against 0.005 M Tris, 0.05 M NaCl, 0.02% EDTA, pH 7.4, for 
conservation. Prior to oxidation, EDTA was removed by dialysis. 
Oxidation was performed by incubation at 37°C of 1 mg LDL pro-
tein/ml with 5.10~6 M CuS04 or of 0.1 mg LDL protein/ml with 
endothelial UNA cells for 24 h in Ham's F10 medium. Control 
LDL was incubated at 37°C for 24 h. In some experiments, LDL 
was modified by the hydroxyl radical (OH-) or by a mixture of OH-
and Superoxide anion 02 - _ . The radicals were generated by gamma 
radiolysis of water using a 60Co irradiator at a radiation dose of 1800 
Gy [15]. The degree of LDL oxidation was checked by determination 
of thiobarbituric-acid-reactive substances (TBARS) according to Yagi 
[16], by measuring conjugated dienes by absorption at 234 nm, and by 
determination of the electrophoretic mobility of the LDL particle. 
Lipid extraction of Cu2+-oxidized LDL was performed according to 
Bligh and Dyer [17]. 
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Table 1 
Characterization of control LDL (c-LDL) and copper (Cu-LDL) or endothelial cell-oxidized LDL (E-LDL) 
TBARS (nmol MDA Eq/mg LDL protein) Conjugated dienes REM 
c-LDL 
E-LDL 
Cu-LDL 
OH-LDL 
OH-+02-"-LDL 
8±2 
44±5 
62±7 
15±2 
54±5 
144%±15 
323% ±35 
455% ±47 
194% ±18 
396% ±41 
1.0 
1.6±0.1 
1.9±0.2 
1.2±0.1 
1.7±0.2 
After EDTA removal by dialysis, LDL modification was performed by a 24 h incubation with CUSO4 5-10-6 M (1 mg LDL protein/ml) or 
endothelial cells (0.1 mg LDL protein/ml) in Ham's F10 medium at 37°C. Control LDL was incubated in the same medium for 24 h at 37°C. LDL 
modification by OH- or (OH-+02-~) was performed as described [15]. Lipid peroxidation end-products (TBARS) were determined by the technique 
of Yagi [17], and conjugated dienes by absorption at 234 nm. The modification of the negative net charge of LDL was assessed by agarose gel-
electrophoresis in a Ciba Corning system and results expressed in relative electrophoretic mobility (REM). Means ± S.D. (« = 5). 
2.4. Preparation of nuclear extracts 
All experiments were performed on sparse cultures, 2 days after 
seeding. The cells were preincubated for 24 h in medium devoid of 
serum and supplemented with 0.1% bovine serum albumin. The cells 
were then incubated with 0.05 mg control or oxidized LDL protein/ml 
for 4 h. In some experiments, the lipid extract of Cu2+-oxidized LDL 
at a concentration equivalent to 0.05 mg LDL protein/ml was intro-
duced in ethanol solution (final concentration 0.3% v/v) during 4 h. dl-
a-Tocopherol 10~5 M was introduced in ethanol solution at the same 
final concentration 24 h before the addition of modified LDL. Cyclo-
heximide when added was introduced 1 h before the addition of oxi-
dized LDL. Nuclear extracts were then prepared according to Dignam 
et al. [18]. Cells were resuspended in 10 mM HEPES, 1.5 mM MgCl2, 
10 mM KC1, 0.5 mM DTT, 0.1% Nonidet P40 and the protease 
inhibitors PMSF 0.2 mM, aprotinin 2 mM, antipain, pepstatin, ben-
zamidine and leupeptin 1 u,g/ml. After homogenization with a Dounce 
homogenizer and a 10 min incubation at 4°C, nuclei were collected by 
centrifugation at 2000 X g for 30 min. The pellet was washed with the 
same buffer without Nonidet P40 and resuspended in 20 mM HEPES 
(pH 7.9), 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM 
DTT, 25% glycerol and the above cited antiproteases. The nuclear 
proteins were extracted by incubation at 4°C during 30 min. After 
centrifugation at 13 000xg for 15 min, the supernatant was kept at 
-80°C. 
2.5. Electrophoretic mobility shift assay 
One strand on the API duplex was 32P-end-labelled with T4 kinase 
and [y-32P]ATP and hybridized with the complementary strand. The 
binding reaction was performed at room temperature for 25 min with 
3-5 ug nuclear protein in 20 ml of 10 mM Tris-HCl (pH 7.5), 50 mM 
NaCl, 0.5 mM DTT, 10% glycerol, 0.2% Nonidet P40, 3 iig poly dl-
dC and 0.1 pmol of the double-stranded labelled probe. The binding 
mixture was submitted to non-denaturing polyacrylamide gel electro-
phoresis. After autoradiography, radioactivity was determined by 
liquid scintillation counting. Each experiment was repeated 2-A times. 
3. Results 
The Cu2+- and endothelial-cell-modified LDL were first 
characterized for the extent of oxidation by determination 
of the lipid peroxidation end-product (TBARS) content, the 
conjugated diene level and the electrophoretic mobility of the 
particle. With these parameters, it was checked that LDL was 
more extensively modified by copper ions than by endothelial 
cells (Table 1). It is of note that, as previously demonstrated 
[15], the hydroxyl radical alone induced only a very slight 
increase in LDL lipid peroxidation as compared to copper-
or endothelial cell-modified LDL, or to LDL modified by the 
hydroxyl radical/superoxide mixture. 
The effect of oxidized LDL on API binding activity was 
studied on different cell types of the arterial wall, namely 
fibroblasts, smooth muscle and endothelial cells. Fig. 1 shows 
that a 4 h treatment with Cu2+- or cell-oxidized LDL induced 
a marked stimulation of API activation in fibroblasts, leading 
to 3.2- and 3.7-fold activation for E-LDL and Cu-LDL, re-
spectively. Control LDL also caused an about 2-fold increase 
in API activity under the same experimental conditions. Cu2+ 
alone had no significant effect on API binding activity (result 
not shown). 
The activation of API was also observed after treatment of 
smooth muscle cells with E-LDL and Cu-LDL (Fig. 2), with a 
more marked effect for Cu-LDL, which initiated an about 6-
fold increase in API activity. Finally, in endothelial cells (Fig. 
3), similar results were obtained: about a 3- and 4-fold stim-
ulation of API activity was observed for E-LDL and Cu-
LDL, respectively. Again, it is of note that control LDL al-
ready induced a significant activation of API in both cell 
types (1.5-2-fold increase in smooth muscle and endothelial 
cells, depending upon the experimental set). It is of note that 
the lipid extract also induced a significant stimulation of API 
binding activity, albeit less marked than that obtained with 
whole Cu-LDL (about 2.5-fold increase for the lipid extract as 
Table 2 
Effect of the antioxidants, a-tocopherol and JV-acetylcysteine on the intracellular TBARS level and API binding activity of endothelial UNA 
cells 
TBARS (%) API binding activity (%) 
M 
None 
Ethanol 0.5% 
a-Tocopherol 10~5 M 
W-Acetylcysteine 5-10-3 
Cu-LDL 
Cu-LDL + a-tocopherol 
Cu-LDL + N-acetylcysteine 
Lipid extract of Cu-LDL 
Lipid extract of CU-LDL + a-tocopherol 
100 
98 ±8 
61 ±5 
82±7 
147± 11 
62±5 
92±9 
n.d. 
n.d. 
100 
91 ±7 
88 ±7 
91 ±8 
442 ±35 
316±29 
210 ±25 
245 ± 30 
168 ±22 
Cells were pretreated for 24 h with the antioxidants before the addition of 0.05 mg/ml Cu-LDL or its lipid extract during 4 h. The API binding 
activity was determined by electrophoretic mobility shift assay as indicated in the text. The intracellular TBARS was determined by the Yagi 
method [17] (100%: 1.4 nmol Eq MDA/mg cellular protein). Means ± S.D. (« = 3). 
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compared to 4-fold increase for Cu-LDL, Table 2). On the 
other hand, the lipid extract of control L D L had the same 
effect as c-LDL itself (data not shown). 
Fig. 2. Autoradiograph showing the activation of API by oxidized 
LDL in smooth muscle cells. A7r5 cells were preincubated for 24 h 
in medium supplemented with bovine serum albumin 0.1% before 
addition of 0.05 mg/ml control or oxidized LDL for 4 h. Nuclear 
extracts were then prepared according to Dignam et al. [18] and 
API binding activity was determined by electrophoretic mobility 
shift assay. Lane 1 : without LDL. Lane 2 : c-LDL. Lane 3 : E-LDL. 
Lane 4: Cu-LDL. 
Fig. 1. Autoradiograph showing the activation of API by oxidized 
LDL in fibroblasts. MRC5 cells were preincubated for 24 h in me-
dium supplemented with bovine serum albumin 0.1% before addi- Since the enhancement of API binding activity might be 
tion of 0.05 mg/ml control or oxidized LDL for 4 h. Nuclear ex- d u e t 0 a n e f f e c t o f o x i d i z e d L D L o n t h e transcriptional or 
tracts were then prepared according to Dignam et al. 1181 and API . . • .. ■ , .. c ., -, , ~ , 
binding activity was determined by electrophoretic mobility shift as- post- transcnptional regulation of the c-Jun and c-Fos sub-
say. Lane 1: without LDL. Lane 2: c-LDL. Lane 3: E-LDL. Lane units [19], we checked whether it was abolished by cyclohex-
4: Cu-LDL. imide. In endothelial cells, it was found that cycloheximide, as 
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Fig. 3. Autoradiograph showing the activation of API by oxidized 
LDL in endothelial cells. UNA cells were preincubated for 24 h in 
medium supplemented with bovine serum albumin 0.1% before addi-
tion of 0.05 mg/ml control or oxidized LDL for 4 h. Nuclear ex-
tracts were then prepared according to Dignam et al. [18] and API 
binding activity was determined by electrophoretic mobility shift as-
say. Lane 1 : without cells. Lane 2 : without LDL. Lane 3 : E-LDL. 
Lane 4: Cu-LDL. Lane 5: c-LDL. 
expected, reduced the API binding activity (Fig. 4). However, 
the activation of API by Cu-LDL was still observed in the 
Fig. 4. Autoradiograph showing the effect of cycloheximide on the 
activation of API by oxidized LDL in endothelial cells. UNA cells 
were preincubated for 24 h in medium supplemented with bovine se-
rum albumin 0.1% and cycloheximide 10 ug/ml was introduced 1 h 
before the addition of Cu-LDL 0.05 mg/ml for an additional 4 h in-
cubation. Lane 1: without LDL. Lane 2: Cu-LDL. Lane 3: cyclo-
heximide. Lane 4: Cu-LDL + cycloheximide. 
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Fig. 5. Autoradiograph showing the effect of OH- and (OH-+02-~) 
modified LDL on API activity. The experimental conditions were 
the same as described in Fig. 1 legend. Generation of OH- and 
(OH-+02-~) was obtained by gamma radiolysis of water using a 
60Co irradiator at a dose of 1800 Gy [15]. Lane 1: without LDL. 
Lane 2: c-LDL. Lane 3: OH-+02-". Lane 4: OH--LDL. 
presence of cycloheximide, indicating an effect of Cu-LDL on 
the post-translational regulation of the API subunits. 
The next experiment was designed to test the effect of the 
antioxidants, oc-tocopherol and TV-acetylcysteine, on the intra-
cellular TBARS level and on Cu-LDL-induced API activation 
in endothelial cells (Table 2). It can be noted that Cu-LDL 
caused an approximately 1.5-fold increase in intracellular 
TBARS. Furthermore, the lipophilic antioxidant, a-tocopher-
ol, whether in the presence or absence of Cu-LDL, reduced 
the TBARS level to approximately 60% of control, whereas 
the hydrophillic antioxidant, N-acetylcysteine had no effect. 
Concerning the API binding activity, both antioxidants had 
no significant effect by themselves, but reduced the Cu-LDL-
induced API activation, with a more marked effect for N-
acety ley steine. 
Finally, in order to further investigate the influence of the 
degree of lipid peroxidation of the LDL particle on API acti-
vation, the effect of LDL modified by OH- or by the 
(OH'+Cv -) mixture was tested. It was previously demon-
strated that only (OH'+CV -) modification of LDL is accom-
panied by a significant increase in the TBARS content of the 
particle, although both modified LDL were no longer recog-
nized by the Apo B/E receptor of fibroblasts [15]. Fig. 5 shows 
that the effect of OH--modified LDL was similar to that of 
control LDL, whereas (OH-+Cv_)-modified LDL was much 
more effective in terms of API activation (Fig. 5). 
4. Discussion 
Our experiments clearly demonstrate that Cu2+- and cell-
oxidized LDL induced API DNA binding activity in fibro-
blasts, smooth muscle and endothelial cells (Figs. 1-3). This 
phenomenon was still observed in the presence of cyclohex-
imide (Fig. 4), which indicated that, at least under our exper-
imental conditions, oxidized LDL exerts its effect by a post-
translational mechanism on the API c-Fos and c-Jun sub-
units, possibly via JNKs and FRK kinases [19]. 
It is of note that the poorly oxidized control LDL already 
initiated an increase in API activity. This phenomenon might 
be interpreted by the fact that the API subunits are very 
sensitive to the redox state of the cell [20], by means of the 
conserved cysteine residues included in their DNA-binding 
domains [21,22]. Alternatively, native LDL might act via a 
signal-transduction pathway: indeed, it has been reported 
that the LDL particle stimulates the production of diacyl-
glycerol, induces the release of Ca2+ from intracellular pools 
and activates protein kinase C in alveolar type II cells [23] and 
human fibroblasts [24]. Resink et al. [25] also demonstrated 
that, in rat smooth muscle cells, native LDL stimulates the 
accumulation of inositol phosphates. 
It can be noted (Table 1) that the extent of API activation 
is approximately parallel to the degree of LDL oxidative mod-
ification in that the extensively oxidized Cu-LDL more effi-
ciently activated API than the cell-oxidized LDL. In addition, 
we have observed that the lipid extract of Cu-LDL also in-
duces the activation of API, which suggests an involvement of 
lipid peroxidation products in the observed phenomenon. In a 
recent report, Ares et al. [26] described a stimulating effect of 
API by Cu-LDL or its lipid extract in human vascular 
smooth muscle cells, but found no relationship to the extent 
of LDL peroxidation. These authors mainly ascribed the ob-
served effect to lysophosphatidylcholine arising from LDL 
phosphatidylcholine partial hydrolysis which accompanies 
LDL oxidative modification [26]. In our experimental model, 
lysophosphatidylcholine also induced API activation in the 
studied cell type (data not shown). However, the partial in-
hibition by vitamin E of the API activation induced by Cu-
LDL or its lipid extract observed in our system suggests that 
lipid peroxidation products could participate in the observed 
phenomenon. First, one can suppose that polyunsaturated 
fatty acid hydroperoxides delivered to cells by oxidized LDL 
could, in the presence of ferrous ions, or by reacting with 
intracellular Superoxide anion, generate the alkoxyl radical 
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[27] which might further induce cellular lipid peroxidation. In 
this hypothesis, vitamin E could exert its protective action by 
blocking the intracellular lipid peroxidation initiated by the 
hydroperoxides included in oxidized L D L . This is in accord-
ance with the results presented in Table 2, which show that 
vitamin E inhibited the increase in intracellular T B A R S con-
tent induced by Cu-LDL. It is also of interest to note that 
hydroxy-eicosa-tetraenoic acids derived from arachidonic acid 
by the lipoxygenase pathway have been demonstrated to acti-
vate API [28]. Thus, hydroperoxides contained in Cu-LDL or 
secondarily generated inside the cells could also act by them-
selves. Second, among the lipid peroxidation end-products 
contained in oxidized LDL, aldehydes such as 4-hydroxyno-
nenal are known to strongly react with SH groups and to 
reduce the cellular glutathione level [29], thus affecting the 
redox state of the cell, which is known to play a crucial role 
in the regulation of API activity [20]. Recent studies by Pin-
kus et al. also confirmed the role of the intracellular gluta-
thione level in API activation [30]. Thus oxidized L D L could 
also activate API by means of its lipid peroxidation end-prod-
ucts such as 4-hydroxynonenal and other aldehydes inducing 
a depletion in intracellular glutathione. This hypothesis is 
supported by the fact that the hydrophilic antioxidant thiol 
compound iV-acetylcysteine also reduced, and more efficiently 
than vitamin E, the activation of API by Cu-LDL (Table 2). 
In summary, the effects of vitamin E and 7V-acetylcysteine 
observed under our experimental conditions would be difficult 
to explain if lysophosphatidylcholine was the only factor in-
volved in oxidized LDL-induced API activation. We therefore 
suggest that, besides lysophosphatidylcholine, lipid peroxida-
tion intermediary or/and end-products contained in oxidized 
L D L could also play a role in A P I activation. 
API binding sites are important for the transcriptional reg-
ulation of several cytokines involved in inflammation such as 
tumor necrosis factor alpha [31,32] or interleukin-1 beta [33]. 
Also, the D N A binding activity of API is essential for the 
regulation of genes involved in cell growth and differentiation 
[34]. Furthermore, the pathogenesis of atherosclerosis is 
closely linked to the mechanism associated with inflammation 
and fibroproliferative repair [35]. Thus, the observed activa-
tion of A P I in the three cell types present in the artery wall 
might be related to the essential role of oxidized L D L in the 
generation and progression of atherosclerosis. 
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